Dyax Corp. Announces Expansion of Executive Roles
All Corporate Functions Consolidated Under Three Executive Vice Presidents to Meet Evolving Business Needs
09-Jun-2011
- USA
Dyax Corp. announced an expansion of roles for the Company's Executive Vice Presidents aimed at meeting the Company's evolving business needs and strategic initiatives. Under the new reporting structure, all corporate functions will report to these executives, who will, in turn, continue to report to Gustav Christensen, President and Chief Executive Officer of Dyax. The executives and their responsibilities are:
- Ivana Magovčević-Liebisch, PhD, JD, who has been with Dyax since 2001, has been named Executive Vice President, Chief Business Officer and General Counsel. In this role, she will now oversee all aspects of Dyax's Commercial Operations and will continue to manage Business Development, Alliance Management and Legal Affairs.
- George Migausky, Dyax's Executive Vice President and Chief Financial Officer since 2008, will add Corporate Communications, Investor Relations and Corporate Compliance to his oversight of Accounting, Finance, Information Technology and Human Resources.
- William Pullman, BMedSc, MB, BS, PhD, FRACP, who has been at Dyax since 2007 and was named Executive Vice President, Chief Research and Development Officer in 2010, will continue to oversee all aspects of Research, Clinical Development, Regulatory Affairs, Medical Affairs and Technical Operations.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
